Home
About
Overview
Sharing Data
ORCID
Help
History (27)
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee.
Drug dosing in cancer patients with decreased kidney function: A practical approach.
Defining R-squared measures for mixed-effects location scale models.
Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles.
Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.
See All 27 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.
Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells. Hum Gene Ther. 2019 07; 30(7):906-917.
View in:
PubMed
subject areas
Animals
Biomarkers
Bone Morphogenetic Protein 2
Bone Regeneration
Cell Differentiation
Cells, Cultured
Disease Models, Animal
Fetal Blood
Gene Expression
Gene Order
Gene Transfer Techniques
Genetic Therapy
Genetic Vectors
Humans
Lentivirus
Mesenchymal Stem Cell Transplantation
Mice
Phenotype
Transduction, Genetic
Transgenes
authors with profiles
Sofia Bougioukli